In 2018, I delved into ketamine infusion therapy, expecting a focus on its neuroscience and psychiatric foundations. Instead, I found that many providers, including non-medical practitioners, treated ketamine primarily as a psychedelic therapy rather than acknowledging its scientifically supported role in enhancing neuroplasticity. Although scientific literature highlights ketamine's therapeutic effects through NMDA receptor interaction and neuroplasticity stimulation, much of the education in the field emphasizes subjective psychedelic experiences instead of these physiological mechanisms.
This shift has led to an echo chamber dominated by psychedelic advocacy, which often overshadows the evidence-based benefits of ketamine's sub-anesthetic effects on neuroplasticity. Consequently, patients may miss opportunities to leverage cognitive and mood improvements post-treatment.
Ketamine-assisted psychotherapy, influenced by the psychedelic movement of the 60s and 70s, suggests that the drug's altered state can facilitate psychological breakthroughs. However, this approach relies on anecdotal evidence, and the altered state might only temporarily alter mindset through heightened suggestibility rather than yielding deeper insights. Moreover, exploring trauma under ketamine's influence could potentially reinforce negative patterns or complicate traumatic memories.
True therapeutic benefits from ketamine arise from its ability to enhance neuroplasticity in the days following treatment. Patient education should emphasize self-management and healthy coping strategies rather than seeking immediate breakthroughs.
In our session, we will present our research on ketamine’s effects on mental health and chronic pain, introducing Minimally-Stimulated Ketamine Infusion Therapy (MSKIT®). MSKIT® protocols, which emphasize safety and long-term improvement, include continuous monitoring, avoidance of sedatives, and high-quality administration by CRNAs to maximize lasting mental health benefits.
Learning Objectives:
Gain insight into ketamine’s mechanism of action, focusing on its interaction with NMDA receptors and its role in enhancing neuroplasticity.
Dispel common myths about ketamine infusion therapy, clarifying misconceptions and highlighting evidence-based practices in order to educate patients effectively, setting realistic expectations and enhancing treatment outcomes.
Identify evidence-based rationales and protocols for the administration of sub-anesthetic intravenous ketamine.
